1.A Family with Congenital Dysfibrinogenemia and Blood Transfusion.
Xiang-Cheng LIAO ; Shan-Shan ZHANG ; Zi-Ji YANG ; Chun-Li ZHU ; Hui-Ni HUANG ; Rui-Xian LUO ; Si-Na LI ; Hui-Qiong XIE ; Hai-Lan LI ; Zhu-Ning MO
Journal of Experimental Hematology 2023;31(5):1469-1474
		                        		
		                        			OBJECTIVE:
		                        			To investigate a family with congenital dysfibrinogenemia, and analyze the risk of hemorrhage and thrombosis and blood transfusion strategies.
		                        		
		                        			METHODS:
		                        			Prothrombin time (PT), activated partial thromboplastin time (APTT) and thrombin time (TT) of the proband and her family members were detected by automatic coagulometer, fibrinogen (Fg) activity and antigen were detected by Clauss method and PT algorithm respectively. Meanwhile, thromboelastometry was analyzed for proband and her family members. Then, peripheral blood samples of the proband and her family members were collected, and all exons of FGA, FGB and FGG and their flanks were amplified by PCR and sequenced to search for gene mutations.
		                        		
		                        			RESULTS:
		                        			The proband had normal APTT and PT, slightly prolonged TT, reduced level of Fg activity (Clauss method). The Fg of the proband's aunt, son and daughter all decreased to varying degrees. The results of thromboelastogram indicated that Fg function of the proband and her family members (except her son) was basically normal. Gene analysis showed that there were 6233 G/A (p.AαArg35His) heterozygous mutations in exon 2 of FGA gene in the proband, her children and aunt. In addition, 2 polymorphic loci were found in the family, they were FGA gene g.9308A/G (p.AαThr331Ala) and FGB gene g.12628G/A (p.BβArg478Iys) polymorphism, respectively. The proband was injected with 10 units of cryoprecipitate 2 hours before delivery to prevent bleeding, and no obvious bleeding occurred during and after delivery.
		                        		
		                        			CONCLUSION
		                        			Heterozygous mutation of 6233G/A (p.AαArg35His) of FGA gene is the biogenetic basis of the disease in this family with congenital dysfibrinogenemia.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fibrinogen/genetics*
		                        			;
		                        		
		                        			Pedigree
		                        			;
		                        		
		                        			Afibrinogenemia/genetics*
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Blood Transfusion
		                        			
		                        		
		                        	
2.Advances in Mechanisms of Blood Brain Barrier Impairment Induced by Sleep Deprivation.
Ji-Xiang ZHU ; Yu-Lin HUANG ; Kun NI ; Yue LIU ; Zheng-Liang MA
Acta Academiae Medicinae Sinicae 2022;44(5):885-890
		                        		
		                        			
		                        			Sleep deprivation,the process and state of partial or complete lack of normal sleep caused by various factors,is prevalent at present.Seriously impairing the physical and mental health,sleep deprivation has become a public health problem that cannot be ignored.Studies have demonstrated that blood-brain barrier impairment is the key pathophysiological process of a variety of neurological diseases.Although clinical and basic studies have suggested that sleep deprivation can induce blood-brain barrier impairment,the underlying mechanisms remain to be elucidated.This review summarizes the advances in the mechanisms of blood-brain barrier impairment induced by sleep deprivation.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Sleep Deprivation/complications*
		                        			;
		                        		
		                        			Blood-Brain Barrier
		                        			;
		                        		
		                        			Brain
		                        			
		                        		
		                        	
		                				3.DNA barcoding of Gentiana crassicaulis  in Lijiang and evaluation of root processing methods
		                			
		                			Wen-jing JI ; Yu-xuan ZHANG ; Zhi-li ZHAO ; Liang-hong NI ; Wei-tao LI ; Chen-xin ZHU ; Xiang CHEN ; Shao-hua YANG
Acta Pharmaceutica Sinica 2022;57(2):507-513
		                        		
		                        			
		                        			 The key factors for producing the best quality Chinese herbal medicines are high-quality germplasm, suitable cultivation area and the proper processing methods for herbal raw materials. 
		                        		
		                        	
4.Gene Sequencing Analyses of 10 ABO Ambiguous Blood Group Samples.
Hui Ni HUANG ; Zhu Ning MO ; Xiang Cheng LIAO ; Zi Ji YANG ; Yue Rong WEI ; Chun Li ZHU ; Hai Lan LI
Journal of Experimental Hematology 2022;30(4):1193-1197
		                        		
		                        			OBJECTIVE:
		                        			Through analysis of ABO blood group gene typing technology, to assist in the identification of difficult clinical serological specimens.
		                        		
		                        			METHODS:
		                        			A total of 10 forwardreverse typing ambiguous samples were collected from January 2021 to August 2021 in our hospital.ABO genotypes were analysed by gene sequencing.
		                        		
		                        			RESULTS:
		                        			The genotypes of 10 ABO ambiguous blood group samples were A102/BW11, A102/BW12, O02/O02, A102/B303, A102/B101, BW11/O02, B101/O04, BW11/O01, BW11/O01, A101/O02, respectively. The genotype results of 6 cases was consistent with the serological phenotype, and the serological phenotype of 4 cases were different from the geno sequencing.
		                        		
		                        			CONCLUSION
		                        			ABO blood groups genotyping technology combined with serological typing can be used for accurate typing of ambiguous blood group, and better ensure the safety of blood transfusion.
		                        		
		                        		
		                        		
		                        			ABO Blood-Group System/genetics*
		                        			;
		                        		
		                        			Alleles
		                        			;
		                        		
		                        			Blood Grouping and Crossmatching
		                        			;
		                        		
		                        			Exons
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Phenotype
		                        			
		                        		
		                        	
5.The correlation between age-related hearing loss and cognitive impairment.
Tong Xiang DIAO ; Ji Lei ZHANG ; Ni Shan CHEN ; Xin MA ; Li Sheng YU ; Hong Wei ZHENG ; Yuan Yuan JING ; Lin HAN ; Yi Xu WANG ; Lin SU ; Lin WANG ; Xue Shi LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2021;56(2):187-192
6.Effect of Low-Fat and Low-Energy Diet on Abdominal Ultrasound Examination:A Preliminary Study
Dan-ni HE ; Kun YUAN ; An-ran LIU ; Qiao JI ; Feng-ping LIANG ; Lu-jing LI ; Xian-xiang WANG ; Zuo-feng XU
Journal of Sun Yat-sen University(Medical Sciences) 2021;42(1):139-144
		                        		
		                        			
		                        			ObjectiveTo explore the effect of low-fat and low-energy diet on the ultrasound examination of liver, gallbladder and pancreas of participants. MethodsFrom January 2020 to September 2020,a total of 30 participants were enrolled in this study. Using self-controlled research method, firstly, ultrasound scans were performed to them for scanning some organs (such as pancreas, left liver and gallbladder) after fasting more than 8 hours, then the participants were told to eat the low-fat and energy foods (steamed bread and porridge), and five times of the same ultrasound scans were performed to them at 0.5 h, 1 h, 2 h, 3 h and 4 h after the meal. Every participant was tested in the above 6 groups. The ultrasound images were blindly evaluated, and gallbladder volumes were compared by two sonographers. The single-factor method of repeated measurement was used to evaluate the ultrasound image qualities of different groups and to compare the gallbladder volumes. ResultsThe difference had no statistical significance in imaging quality of pancreas and left liver between each postprandial group and fasting group (P > 0.05). Among the most concerned gallbladder ultrasound image quality, the difference had no statistical significance between groups (F=0.7, P=0.6). For the percentage of gallbladder volume, the difference had no statistical significance between groups (F=1.8, P=0.2). ConclusionCompared with the ultrasound examination under an 8-hour fasting state, the ultrasound images of abdominal organs (such as liver, pancreas and gallbladder) and the gallbladder volumes are not affected by the low-fat and low-energy diets. 
		                        		
		                        		
		                        		
		                        	
7.Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
Jie WU ; Shu-Wei DUAN ; Hong-Tao YANG ; Yue-Yi DENG ; Wei LI ; Ya-Ni HE ; Zhao-Hui NI ; Yong-Li ZHAN ; Shan LIN ; Zhi-Yong GUO ; Jun ZHU ; Jing-Ai FANG ; Xu-Sheng LIU ; Li-Hua WANG ; Rong WANG ; Nian-Song WANG ; Xiao-Hong CHENG ; Li-Qun HE ; Ping LUO ; Shi-Ren SUN ; Ji-Feng SUN ; Ai-Ping YIN ; Geng-Ru JIANG ; Hong-Yu CHEN ; Wen-Hu LIU ; Hong-Li LIN ; Meng LIANG ; Lu MA ; Ming CHEN ; Li-Qun SONG ; Jian CHEN ; Qing ZHU ; Chang-Ying XING ; Yun LI ; Ji-Ning GAO ; Rong-Shan LI ; Ying LI ; Hao ZHANG ; Ying LU ; Qiao-Ling ZHOU ; Jun-Zhou FU ; Qiang HE ; Guang-Yan CAI ; Xiang-Mei CHEN
Journal of Integrative Medicine 2021;19(2):111-119
		                        		
		                        			BACKGROUND:
		                        			Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.
		                        		
		                        			OBJECTIVE:
		                        			This trial compared the efficacy and safety of SYKFT, for the control of proteinuria in primary glomerulonephritis patients, against the standard drug, losartan potassium.
		                        		
		                        			DESIGN, SETTING, PARTICIPANTS AND INTERVENTION:
		                        			This was a multicenter, double-blind, randomized, controlled clinical trial. Primary glomerulonephritis patients, aged 18-70 years, with blood pressure ≤ 140/90 mmHg, estimated glomerular filtration rate (eGFR) ≥ 45 mL/min per 1.73 m
		                        		
		                        			MAIN OUTCOME MEASURES:
		                        			The primary outcome was change in the 24-hour proteinuria level, after 48 weeks of treatment.
		                        		
		                        			RESULTS:
		                        			A total of 735 participants were enrolled. The percent decline of urine protein quantification in the SYKFT group after 48 weeks was 8.78% ± 2.56% (P = 0.006) more than that in the losartan 50 mg group, which was 0.51% ± 2.54% (P = 1.000) less than that in the losartan 100 mg group. Compared with the losartan potassium 50 mg group, the SYKFT plus losartan potassium 50 mg group had a 13.39% ± 2.49% (P < 0.001) greater reduction in urine protein level. Compared with the losartan potassium 100 mg group, the SYKFT plus losartan potassium 100 mg group had a 9.77% ± 2.52% (P = 0.001) greater reduction in urine protein. With a superiority threshold of 15%, neither was statistically significant. eGFR, serum creatinine and serum albumin from the baseline did not change statistically significant. The average change in TCM syndrome score between the patients who took SYKFT (-3.00 [-6.00, -2.00]) and who did not take SYKFT (-2.00 [-5.00, 0]) was statistically significant (P = 0.003). No obvious adverse reactions were observed in any group.
		                        		
		                        			CONCLUSION:
		                        			SYKFT decreased the proteinuria and improved the TCM syndrome scores of primary glomerulonephritis patients, with no change in the rate of decrease in the eGFR. SYKFT plus losartan potassium therapy decreased proteinuria more than losartan potassium therapy alone.
		                        		
		                        			TRIAL REGISTRATION NUMBER
		                        			NCT02063100 on ClinicalTrials.gov.
		                        		
		                        		
		                        		
		                        	
8.Status of hemodialysis and qualified status of dialysis water and dialysate in a city
Xiu-Zhen WANG ; Mei-Zhen QIAO ; Mei-Juan JIN ; Xue-Feng QIAN ; Jun-Ji ZHANG ; Xiao-Yan NI ; Na-Xing ZHAO ; Zheng XU ; Qin-Ying ZHANG ; Xiang-Ming YAN ; Xin-Fang LI
Chinese Journal of Infection Control 2018;17(4):325-328
		                        		
		                        			
		                        			Objective To investigate current status of hemodialysis,and qualified status of dialysis water and dia-lysate in a city. Methods Status of hemodialysis in 36 medical institutions in a city which conducted blood purifica-tion programme was surveyed,dialysis water and dialysate were collected to perform microbial detection(including conventional and low temperature culture methods)and on-site ATP detection.Results 13.89% of equipments for water treatment were used less than 1 year,5.56% were used for more than 10 years. 77.78% of medical institu-tions didn't replace sand filtration which had been used for more than 1 year,the replacement time of 72.22% of fil-ter core was less than 3 months,2.78% of reverse water supply pipeline was used for more than 10 years.77.78%of medical institutions used finished A solution,72.22% used finished B solution,22.22% used centrally provided A solution,19.44% used centrally provided B solution,and 8.34% used self-made B solution. Routine microbial detection in 36 medical institutions were qualified,but 80.56% of detection results were"0" value for long period;ATP detection of on-site collected dialysis water and dialysate were all qualified. One specimen for microbial detec-tion under normal temperature exceeded the standard,2 reached the intervention value;4 specimens for microbial detection under low temperature exceeded the standard,6 reached the intervention value;qualified rates of 3 kinds of detection methods among different levels of medical institutions weren't significantly different(all P>0.05).Con-clusion The overall quality of hemodialysis water and dialysate in this city is good,the majority of medical institutions pay attention to the routine maintenance of water treatment equipment,detect the quality of hemodialysis water and dialysate regularly,but microbial detection technique needs to be improved,causes for abnormal results or intervention value of rou-tine detection needs to be analyzed and improved continuously.
		                        		
		                        		
		                        		
		                        	
9.Molecular Characterization and Correlation with β-lactam Resistance of Streptococcus pneumonia Isolates in Hangzhou, China.
Mei Fen CHU ; Xiao Xiang LIU ; Shao Ni ZHANG ; Yan Ying HUANG ; Peng DU ; Li Fang WANG ; Lei JI ; Jie YAN ; Ai Hua SUN
Biomedical and Environmental Sciences 2018;31(5):389-393
		                        		
		                        			
		                        			Penicillin-binding proteins (PBPs) are the target of β-lactam antibiotics (the major treatment for Streptococcus pneumoniae infections), and mutations in PBPs are considered as a primary mechanism for the development of β-lactam resistance in S. pneumoniae. This study was conducted to investigate the mutations in the PBPs of clinical S. pneumoniae isolates in Hangzhou, China, in correlation with β-lactam resistance. Results showed that 19F was the predominant serotype (7/27) and 14 of the S. pneumoniae isolates were resistant to both penicillin G and cephalosporin. Genotyping results suggested that β-lactam-resistant isolates primarily exhibited single-site mutations in both the STMK and SRNVP motifs of pbp1a in combination with double-site mutations in the STMK motif of pbp2x, which might be the primary mechanisms underlying the β-lactam resistance of the isolates in this study.
		                        		
		                        		
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Drug Resistance, Bacterial
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Pneumococcal Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			microbiology
		                        			;
		                        		
		                        			Streptococcus pneumoniae
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			beta-Lactams
		                        			;
		                        		
		                        			pharmacology
		                        			
		                        		
		                        	
10.Metabolic Characteristics of Leucocyte-deplated and Suspended RBC Produced by Using Lipid Whole Blood During Routine Storage.
Jun-Hong YANG ; Yu-Lin JIANG ; Yi-Feng LIU ; Zhi-Qian ZHANG ; Chang-Li ZHONG ; Nian WANG ; Fei-Hu JI ; Qian-Ni JIN ; Xiang-Sen YE ; Ting-Mei CHEN
Journal of Experimental Hematology 2018;26(2):584-588
OBJECTIVETo investigate the differences of metabolic pathways of leucocyte-deplated RBCs prepared by using lipid whole blood and nomal blood during routine storage so as to provide some reference for clinical blood use.
METHODSTwenty U whole blood from 20 donors, including 10 U lipid blood and 10 U normal whole blood, were selected for preparing leukodepleted red blood cells, red blood cells were taken from storage bags on day 0, 14 and 35, respectively. Metabolites in the red blood cells were analyzed, red blood cell metabolic extracts were detected by UPLC-MS/MS. The metabolite data of RBC from 2 groups were analyzed by SIMCA-P 13.0 software using OPLS-DA and by SPSS 19.0 using Mann-Whitney U test. Difference of metabolic pathways was described according to different metabolites.
RESULTSThe glucose, adenine, pyruvic acid, GSH, GSSG and niacinamide levels on day 0 in lipid RBCs were higher than those in the control group(P<0.05). The glucose, pyruvic acid and GSH levels on day 14 in lipid RBCs were lower than those in the control group (P<0.05), and the levels of adenine, GSSG and niacinamide were higher than that in the control group (P<0.05). The glucose level on day 0 was lower than that in the control group (P<0.05), and the levels of adenine and niacinamide were higher than those in the control group (P<0.05). but the pyruvic acid, GSH and GSSG levels were not significantly different between 2 groups (P>0.05).
CONCLUSIONCompared with the normal red blood cells, the energy metabolism pathway decreases in lipid red blood cells within the storage period and pentose phosphate pathway increases.
Blood Preservation ; Erythrocytes ; Glucose ; Humans ; Lipids ; Tandem Mass Spectrometry
            
Result Analysis
Print
Save
E-mail